Relay Therapeutics, Inc. (RLAY)
18.18
-0.16
(-0.87%)
USD |
NASDAQ |
Oct 23, 16:00
18.18
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics Price : 18.18 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 18.03 | 18.26 | 17.68 | 18.18 | 1.899M |
| Oct 22, 2026 | 18.28 | 18.71 | 18.02 | 18.34 | 1.722M |
| Oct 21, 2026 | 18.61 | 19.03 | 18.19 | 18.41 | 1.598M |
| Oct 20, 2026 | 17.03 | 18.69 | 17.01 | 18.45 | 1.976M |
| Oct 19, 2026 | 16.53 | 17.21 | 16.38 | 17.09 | 1.749M |
| Oct 16, 2026 | 17.17 | 17.17 | 16.13 | 16.28 | 2.367M |
| Oct 15, 2026 | 17.15 | 17.56 | 17.07 | 17.30 | 2.117M |
| Oct 14, 2026 | 17.02 | 17.77 | 16.90 | 17.06 | 2.937M |
| Oct 13, 2026 | 17.84 | 17.94 | 17.27 | 17.36 | 1.706M |
| Oct 12, 2026 | 17.77 | 18.32 | 17.53 | 17.98 | 2.091M |
| Oct 09, 2026 | 17.01 | 18.50 | 17.01 | 17.88 | 1.765M |
| Oct 08, 2026 | 17.71 | 17.97 | 16.87 | 17.41 | 4.333M |
| Oct 07, 2026 | 18.40 | 18.54 | 17.85 | 17.95 | 3.433M |
| Oct 06, 2026 | 19.50 | 19.50 | 18.17 | 18.74 | 3.880M |
| Oct 05, 2026 | 19.00 | 19.40 | 18.28 | 19.39 | 2.936M |
| Oct 02, 2026 | 18.71 | 19.13 | 18.60 | 18.96 | 2.771M |
| Oct 01, 2026 | 18.02 | 19.08 | 17.86 | 18.49 | 2.824M |
| Sep 30, 2026 | 18.39 | 18.72 | 17.93 | 18.05 | 2.783M |
| Sep 29, 2026 | 17.65 | 18.48 | 17.52 | 18.36 | 3.589M |
| Sep 28, 2026 | 17.10 | 17.88 | 17.05 | 17.69 | 1.846M |
| Sep 25, 2026 | 17.94 | 18.01 | 17.42 | 17.47 | 2.984M |
| Sep 24, 2026 | 18.09 | 18.09 | 17.41 | 17.73 | 3.676M |
| Sep 23, 2026 | 19.15 | 19.23 | 17.22 | 18.03 | 4.708M |
| Sep 22, 2026 | 18.43 | 19.48 | 18.21 | 19.35 | 3.632M |
| Sep 21, 2026 | 19.07 | 19.17 | 18.05 | 18.19 | 3.030M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| SELLAS Life Sciences Group, Inc. | 11.54 |
| TG Therapeutics, Inc. | 54.17 |
| Karyopharm Therapeutics, Inc. | 0.5175 |
| Spyre Therapeutics, Inc. | 90.33 |
| Akebia Therapeutics, Inc. | 0.5669 |
Price Related Metrics
| PS Ratio | 319.90 |
| Price to Book Value | 4.464 |
| Earnings Yield | -8.62% |
| Market Cap | 3.973B |